COVID-19 Information
If you're planning a visit to one of our locations, please use our prescreen app before you arrive. If you have cold or flu symptoms or have tested positive for COVID-19 in the last 20 days, please call your doctor's office before your appointment. You can call 617-632-3000 or find your doctor's number in our online directory.
At Dana-Farber, your health and safety are our top priorities.
COVID-19 Information for Patients and Visitors
Patient safety and quality of care are our top priorities. Learn about our revised visitor and mask policy and what you need to know before your visit to Dana-Farber.
COVID-19 Therapies and Vaccines for Patients
COVID-19 therapies can help your immune system fight a COVID-19 infection, while vaccines help prevent infection. If you are not already fully vaccinated, we strongly encourage you to get the COVID-19 vaccine to protect yourself and your loved ones.
COVID-19 Research at Dana-Farber
Dana-Farber is applying its pioneering research tradition to developing novel approaches towards understanding and treating COVID-19. We are developing groundbreaking therapeutic strategies, and are collaborating with fellow scientists worldwide.
Recovered from COVID-19? Help researchers make discoveries against COVID-19
A Dana-Farber research team, led by Wayne A. Marasco, MD, PhD, is conducting a COVID-19 Protective Immunity Study to better understand the key factors that influence human immune responses to the SARS-CoV2, as well as develop novel, effective and durable broad-spectrum SARS-CoV vaccines.
Health care workers, cancer patients, or otherwise healthy individuals who recovered from COVID-19 infection are asked to consider participating in this study. 150 volunteers will be enrolled during and shortly after the COVID-19 pandemic period.
Joining the COVID-19 Protective Immunity Study is simple. Learn more and provide your contact information. A research nurse will then contact you. For detailed information, please read the COVID-19 Protective Immunity Study recruitment literature.
Clinicians, please make cancer patients who have recovered from COVID-19 infections aware of this study.